Has Roy Escobar received payments from drug or device companies?

Yes. Drug and device makers reported $3,322 in general payments to Roy Escobar across 84 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roy Escobar did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roy Escobar come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roy Escobar

Neurology · Kalispell, MTNPI 1376120030

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Medtronic at 29.1% of the total. 2025 is the largest year on record at $1,550, 2.1 times the $743 reported in 2023.

$3,322in general payments, 2019–2025

Across 84 payments — averaging $39.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$968
AbbVie$296
Neurocrine Biosciences, Inc.$262
Jazz Pharmaceuticals Inc.$188
Stryker$166
EMD Serono, Inc.$146
plus $1K from 21 others

What the payments were for

Food & beverage$3,322100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	9	$968
AbbVie	12	$296
Neurocrine Biosciences, Inc.	5	$262
Jazz Pharmaceuticals Inc.	2	$188
Stryker	1	$166
EMD Serono, Inc.	2	$146
Genentech USA, Inc.	6	$136
Novartis	6	$133
SK Life Science, Inc.	2	$118
Biogen	4	$99
Takeda Pharmaceuticals U.S.A., Inc.	4	$97
UCB, Inc.	4	$91
Lundbeck LLC	3	$85
AstraZeneca	4	$84
TG Therapeutics, Inc.	3	$75
Ipsen Biopharmaceuticals, Inc	2	$45
Otsuka America Pharmaceutical, Inc.	2	$43
Vanda Pharmaceuticals Inc.	2	$41
Pfizer	2	$36
Immedica Pharma US, Inc.	1	$35
ANI Pharmaceuticals, Inc.	1	$35
Merz Pharmaceuticals, LLC	1	$34
Lilly USA, LLC	2	$33
Livanova USA, Inc.	1	$26
E.r. Squibb & Sons, L.L.C.	1	$19
Octapharma USA, Inc.	1	$18
Azurity Pharmaceuticals, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,322 in reported general payments places this provider in the 65th percentile of 48 neurology providers in Montana.

See all neurology providers in Montana →

Other neurology in Kalispell

Norman FriedmanKalispell$35K
Kurt LindsayKalispell$5K
Tanner FerdererKalispell$4K
Bret LindsayKalispell$166
Melanie KlawiterKalispell$141
Donald StoneKalispell$70
Kristin YandoraKalispell$40
Ann CollierBillings$164K
Dennis DietrichGreat Falls$140K
Nicole ClarkHelena$85K

See the full list for Montana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →